Prominent IGF-1R nuclear positivity in the tumor of our patient is of interest, given our previous finding that nuclear IGF-1R in prostate cancer models is induced by ligand and blocked by IGF-1R kinase inhibition (16). Here, IGF1R is linked to prostate carcinoma.